Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice

Neuroscience

Volumn 97, Issue 4, 2000, Pages 685-692

  Cambon, K ^a   Davies, H A ^a   Stewart, M G ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer; ApoE; Electron microscopy; Hippocampus; Morphometry; Transgenic mice

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ELECTRON MICROSCOPY; FEMALE; KNOCKOUT MOUSE; MALE; MORPHOMETRICS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPSE; TRANSGENIC MOUSE;

AGING; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CROSSES, GENETIC; DENDRITES; DENTATE GYRUS; FEMALE; HETEROZYGOTE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; SYNAPSES;

EID: 0034077821     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00065-8     Document Type: Article

References (81)

1. Adams I. Plasticity of the synaptic contact zone following loss of synapses in the cerebral cortex of aging humans. Brain Res. 424:1987;343-351.
2. Amaral D. G. and Witter M. P. (1995) The hippocampal formation. In The Rat Nervous System (ed. Paxinos G.), 2nd edn., Academic, New York.
3. Anderson R., Barnes J.C., Bliss T., Cain D.P., Cambon K., Davies H.A., Errington M.L., Fellows L.A., Gray R.A., Hoh T., Stewart M., Large C.H., Higgins G.A. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience. 85:1998;93-110.
4. Arendt T., Schindler C., Bruckner M.K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J. Neurosci. 17:1997;516-529.
5. Bellosta S., Nathan B.P., Orth M., Dong L.M., Mahley R.W., Pitas R.E. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma-cells produces differential-effects on neurite outgrowth. J. biol. Chem. 270:1995;27,063-27,071.
6. Berr C., Dufouil C., Brousseau T., Richard F., Amouyel P., Marceteau E., Alperovitch A. Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Neurosci. Lett. 218:1996;9-12.
7. Bertrand P., Poirier J., Oda T., Finch C.E., Pasinetti G.M. Association of apolipoprotein-E genotype with brain levels of apolipoprotein-E and apolipoprotein-J (clusterin) in Alzheimer disease. Molec. Brain Res. 33:1995;174-178.
8. Blennow K., Bogdanovic N., Alafuzoff I., Ekman R., Davidsson P. Synaptic pathology in Alzheimer's disease - relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the apoE4 allele. J. neural Transm. 103:1996;603-618.
9. Bobinski M., Wegiel J., Wisniewski H.M., Tarnawski M., Reisberg B., Mlodzik B., Deleon M.J., Miller D.C. Atrophy of hippocampal-formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia. 6:1995;205-210.
10. Bowman B.H., Yang F.M., Buchanan J.M., Adrian G.S., Martinez A.O., Jansen L., Zhao M., Atherton S.L., Hixson J.E. Human ApoE protein localized in brains of transgenic mice. Neurosci. Lett. 219:1996;57-59.
11. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R.E., WyssCoray T., Mucke L., Mahley R.W. Expression of human apolipoprotein E3 or E4 in the brains of Apoe(-/-) mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19:1999;4867-4880.
12. Cabalka L.M., Hyman B.T., Goodlett C.R., Ritchie T.C., Vanhoesen G.W. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions. Neurobiol. Aging. 13:1992;283-291.
13. Calhoun M.E., Kurth D., Phinney A.L., Long J.M., Hengemihle J., Mouton P.R., Ingram D.K., Jucker M. Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice. Neurobiol. Aging. 19:1998;599-606.
14. Cavalieri B. Geometria indivisibilibus continuorum, typis clemetis feronij, Bononi. 1635;Unione tipographico-Editrice torinese, Turin. Reprinted (1966) as Geometria degli indivisibili.
15. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., Small G.W., Roses A.D., Haines J.L., Pericakvance M.A. Protective effect of apolipoprotein E type-2 allele for late-onset Alzheimer-disease. Nat. Genet. 7:1994;180-184.
16. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericakvance M.A. Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer's-disease in late-onset families. Science. 261:1993;921-923.
17. DeGroot D.M.G., Bierman E.P.B., Bruijnzeel P.L.B., Woutersen R.A. The 'disector' - a tool for quantitative assessment of synaptic plasticity: an example on hippocampal synapses and synapse-perforations in ageing rats. Eur. J. Morph. 33:1995;305-309.
18. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27:1990;457-464.
19. DetoledoMorrell L., Sullivan M.P., Morrell F., Wilson R.S., Bennett D.A., Spencer S. Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol. Aging. 1:1997;463-468.
20. Gandy S., Stafstrom C., Turner B., Sweeney D., Breslow J., Greengard P., Smith J., Ouimet C. Aged ApoE deficient mice: abnormal learning and glial markers but no obvious neuropathology. Soc. Neurosci. Abstr. 21:1995;5.
21. Geinisman Y., Detoledomorrell L., Morrell F., Persina I.S., Rossi M. Age-related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique. Hippocampus. 2:1992;437-444.
22. Gerlai R. Gene-targeting studies of mammalian behaviour: is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-181.
23. Hamos J.E., De Gennaro L.J., Drachman D.A. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 39:1989;355-361.
24. Han S.H., Einstein G., Weisgraber K.H., Strittmatter W.J., Saunders A.M., Pericakvance M., Roses A.D., Schmechel D.E. Apolipoprotein-E is localized to the cytoplasm of human cortical-neurons - a light and electron-microscopic study. J. Neuropath. exp. Neurol. 53:1994;535-544.
25. Han S.H., Hulette C., Saunders A.M., Einstein G., Pericakvance M., Strittmatter W.J., Roses A.D., Schmechel D.E. Apolipoprotein-E is present in hippocampal-neurons without neurofibrillary tangles in Alzheimer's-disease and in age-matched controls. Expl Neurol. 128:1994;13-26.
26. Haug H. Giebt es nervenzellverluste wahrend der alterung in der menschlichen hirnrinde? Nervenheilkunde. 4:1985;103-109.
27. Heinonen O., Lehtovirta M., Soininen H., Helisalmi S., Mannermaa A., Sorvari H., Kosunen O., Paljarvi L., Ryynanen M., Riekkinen P.J. Alzheimer pathology of patients carrying apolipoprotein-E epsilon-4 allele. Neurobiol. Aging. 16:1995;505-513.
28. Heinonen O., Soininen H., Sorvari H., Kosunen O., Paljarvi L., Koivisto E., Riekkinen P.J. Loss of synaptophysin-like immunoreactivity in the hippocampal-formation is an early phenomenon in Alzheimer's disease. Neuroscience. 64:1995;375-384.
29. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G.J., Schwartz A.L. Low-density-lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell-line. Proc. natn. Acad. Sci. U.S.A. 92:1995;9480-9484.
30. Honer W.G., Dickson D.W., Gleeson J., Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging. 13:1992;375-382.
31. Horsburgh K., Kelly S., McCulloch J., Higgins G.A., Roses A.D., Nicoll J. Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. NeuroReport. 10:1999;837-841.
32. Horsburgh K., Nicoll J.A.R. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat. Neuropath. appl. Neurobiol. 22:1996;342-349.
33. Howard C.V., Reed M.G. Estimation of reference volume using the Cavalieri method. Unbiased Stereology. 1998;Bios Scientific, Oxford.
34. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
35. Jack C.R., Petersen R.C., Obrien P.C., Tangalos E.G. Mr-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 42:1992;183-188.
36. Jack C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Waring S.C., Tangalos E.G., Smith G.E., Ivnik R.J., Thibodeau S.N., Kokmen E. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann. Neurol. 43:1998;303-310.
37. Jordan J., Galindo M.F., Miller R.J., Reardon C.A., Getz G.S., LaDu M.J. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18:1998;195-204.
38. Juraska J.M., Fitch J.M., Henderson C., Rivers N. Sex differences in the dendritic branching of dentate granule cells following differential experience. Brain Res. 333:1985;73-80.
39. Laskowitz D.T., Sheng H.X., Bart R.D., Joyner K.A., Roses A.D., Warner D.S. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J. cerebr. Blood Flow Metab. 17:1997;753-758.
40. Lassman H., Weiler R., Fischer P., Bancher C., Jellinger K., Floor E., Danielczyk W., Seitelberger F., Winkler H. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience. 46:1992;1-8.
41. Lehtovirta M., Laakso M.P., Soininen H., Helisalmi S., Mannermaa A., Helkala E.L., Partanen K., Ryynanen M., Vainio P., Hartikainen P., Riekkinen P.J. Volumes of hippocampus, amygdala and frontal-lobe in Alzheimer patients with different apolipoprotein-E genotypes. Neuroscience. 67:1995;65-72.
42. Lehtovirta M., Soininen H., Laakso M.P., Partanen K., Helisalmi S., Mannermaa A., Ryynanen M., Kuikka J., Hartikainen P., Riekinnen P.J. Spect and MRI analysis in Alzheimer's-disease - relation to apolipoprotein E epsilon-4 allele. J. Neurol. Neurosurg. Psychiat. 60:1996;644-649.
43. Lippa C.F., Hamos J.E., Pulaskisalo D., Degennaro L.J., Drachman D.A. Alzheimer's disease and aging - effects on perforant pathway perikarya and synapses. Neurobiol. Aging. 13:1992;405-411.
44. Mahley R.W. Apolipoprotein E - cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
45. Masliah E., Mallory M., Ge N.F., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central-nervous-system of ApoE-deficient mice. Expl Neurol. 136:1995;107-122.
46. Masliah E., Mallory M., Hansen L., Deteresa R., Alford M., Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's-disease. Neurosci. Lett. 174:1994;67-72.
47. Masliah E., Terry R.D., Alford M., Deteresa R., Hansen L.A. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's-disease. Am. J. Path. 138:1991;235-246.
48. Miller A., Alford M., Katzman R., Thal L., Saitoh T., Masliah E. The expression of the ApoE4 allele in Alzheimer's disease accentuates the synaptic loss and the severity of the dementia (Abstract). Ann. Neurol. 36:1994;268-269.
49. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein-E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's-disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
50. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential-effects of apolipoproteins E3 and E4 on neuronal growth in-vitro. Science. 264:1994;850-852.
51. Nathan B.P., Chang K.C., Bellosta S., Brisch E., Ge N.F., Mahley R.W., Pitas R.E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. biol. Chem. 270:1995;19,791-19,799.
52. Parker C.A., Callahan M.J., Lipinski W.J., Bisgaier C.L., Walker L.C. Effects of aging on glial and neural markers in apolipoprotein E-deficient mice. Soc. Neurosci. Abstr. 22:1996;207.
53. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein-E gene inactivated by gene targeting in embryonic stem-cells. Proc. natn. Acad. Sci. U.S.A. 89:1992;4471-4475.
54. Poirier J. Apolipoprotein-E in animal-models of CNS injury and in Alzheimer's-disease. Trends Neurosci. 17:1994;525-530.
55. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol-synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult-rats. Neuroscience. 55:1993;81-90.
56. Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein-E messenger-RNA and GFAP messenger-RNA in hippocampus after entorhinal cortex lesioning. Molec. Brain Res. 11:1991;97-106.
57. Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R.E., Mahley R.W., Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. natn. Acad. Sci. U.S.A. 95:1998;10,914-10,919.
58. Rusakov D.A., Harrison E., Stewart M.G. Synapses in hippocampus occupy only 1-2% of cell membranes and are spaced less than half-micron apart: a quantitative ultrastructural analysis with discussion of physiological implications. Neuropharmacology. 37:1998;513-521.
59. Scheff S.W., Price D.A. Synapse loss in the temporal lobe in Alzheimer's-disease. Ann. Neurol. 33:1993;190-199.
60. Scheff S.W., Sparks D.L., Price D.A. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia. 7:1996;226-232.
61. Schmechel D., Saunders A.M., Strittmatter W.J., Crain B., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid β-peptide as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;9649-9653.
62. Seab J.P., Jagust W.J., Wong S.T., Roos M.S., Reed B.R., Budinger T.F. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn. Reson. Med. 8:1988;200-208.
63. Sheng H.X., Laskowitz D.T., Bennett E., Schmechel D.E., Bart R.D., Saunders A.M., Pearlstein R.D., Roses A.D., Warner D.S. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J. cerebr. Blood Flow Metab. 18:1998;361-366.
64. Sheng H.X., Laskowitz D.T., Mackensen G.B., Kudo M., Pearlstein R.D., Warner D.S. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke. 30:1999;1118-1123.
65. Sidman R.L., Angevine J.B., Pierce E.T. Atlas of the Mouse Brain and Spinal Cord. 1971;Harvard University Press, Cambridge, MA.
66. Soininen H.S., Riekkinen P.J. Sr. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19:1996;224-228.
67. Sterio D.C. The unbiased estimation of the number and size of arbitrary particles using the disector. J. Microsc. 134:1984;127-136.
68. Steward O., Scoville S.A. Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat. J. comp. Neurol. 169:1976;347-370.
69. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., Finch C.E. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J. Neurosci. 18:1998;3180-3185.
70. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., Huang D.Y., Pericakvance M., Schmechel D., Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau - implications for Alzheimer-disease. Proc. natn. Acad. Sci. U.S.A. 91:1994;11,183-11,186.
71. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericakvance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid-beta peptide-isoform-specific effects and implications for late-onset Alzheimer-disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;8098-8102.
72. Sun Y.L., Wu S., Bu G.J., Onifade M.K., Patel S.N., LaDu M.J., Fagan A.M., Holtzman D.M. Glial fibrillary acidic protein-apolipoprotein E (ApoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18:1998;3261-3272.
73. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropath. exp. Neurol. 56:1997;933-944.
74. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
75. Tohgi H., Takahashi S., Kato E., Homma A., Niina R., Sasaki K., Yonezawa H., Sasaki M. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon 4 allele. Neurosci. Lett. 236:1997;21-24.
76. Veinbergs I., Mallory M., Mante M., Rockenstein E., Gilbert J.R., Masliah E. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice. Neurosci. Lett. 265:1999;218-222.
77. Xu P.T., Gilbert J.R., Qiu H.L., RothrockChristian T., Settles D.L., Roses A.D., Schmechel D.E. Regionally specific neuronal expression of human ApoE gene in transgenic mice. Neurosci. Lett. 246:1998;65-68.
78. Xu P.T., Schmechel D., Qiu H.L., Herbstreith M., RothrockChristian T., Eyster M., Roses A.D., Gilbert J.R. Sialylated human apolipoprotein E (apoE(s)) is preferentially associated with neuron-enriched cultures from ApoE transgenic mice. Neurobiol. Dis. 6:1999;63-75.
79. Xu P.T., Schmechel D., RothrockChristian T., Burkhart D.S., Qiu H.L., Popko B., Sullivan P., Maeda N., Saunders A.M., Roses A.D., Gilbert J.R. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3:1996;229-245.
80. Yasuda M., Mori E., Kitagaki H., Yamashita H., Hirono N., Shimada K., Maeda K., Tanaka C. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am. J. Psychol. 155:1998;779-784.
81. Zarow C., Victoroff J. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning. Expl Neurol. 149:1998;79-86.